VEXAS Syndrome - A Review of Pathophysiology, Presentation, and Prognosis

Research output: Contribution to journalReview articlepeer-review

Abstract

VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome is a newly identified disease caused by somatic mutations in the UBA1 gene resulting in refractory autoinflammatory features, frequently accompanied by cytopenias. Although the prevalence of this syndrome is yet unknown, understanding the clinical phenotype can assist clinicians in prompt recognition of cases among patients with glucocorticoid-responsive but immunosuppressive-resistant inflammatory symptoms. The pathophysiology, clinical presentation, diagnostic methods, treatment, and prognosis of VEXAS are herein reviewed.

Original languageEnglish (US)
Pages (from-to)298-306
Number of pages9
JournalJournal of Clinical Rheumatology
Volume29
Issue number6
DOIs
StatePublished - Sep 1 2023

Keywords

  • VEXAS
  • autoinflammatory
  • pathophysiology
  • prognosis
  • vasculitis

ASJC Scopus subject areas

  • Rheumatology

Fingerprint

Dive into the research topics of 'VEXAS Syndrome - A Review of Pathophysiology, Presentation, and Prognosis'. Together they form a unique fingerprint.

Cite this